πŸ‡ΊπŸ‡Έ FDA
Patent

US 8927215

GNA11 mutations in melanoma

granted A61PA61P35/00A61P43/00

Quick answer

US patent 8927215 (GNA11 mutations in melanoma) held by The Regents of the University of California expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P35/00, A61P43/00